Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.95
-1.08 (-9.79%)
At close: May 18, 2026, 4:00 PM EDT
10.54
+0.59 (5.93%)
After-hours: May 18, 2026, 4:51 PM EDT
CRBP Market Cap
CRBP has a market cap or net worth of $176.48 million as of May 18, 2026. Its market cap has increased by 91.82% in one year.
Market Cap
176.48M
Enterprise Value
38.93M
1-Year Change
91.82%
Ranking
Category
Stock Price
$9.95
Market Cap Chart
Since November 11, 2014, CRBP's market cap has increased from $75.80M to $176.48M, an increase of 132.82%. That is a compound annual growth rate of 7.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 204.40M | 43.04% |
| Dec 31, 2025 | 142.90M | -0.56% |
| Dec 31, 2024 | 143.70M | 438.20% |
| Dec 29, 2023 | 26.70M | 93.48% |
| Dec 30, 2022 | 13.80M | -82.10% |
| Dec 31, 2021 | 77.10M | -26.57% |
| Dec 31, 2020 | 105.00M | -70.26% |
| Dec 31, 2019 | 353.10M | 5.62% |
| Dec 31, 2018 | 334.30M | -14.19% |
| Dec 29, 2017 | 389.60M | 3.75% |
| Dec 30, 2016 | 375.50M | 505.65% |
| Dec 31, 2015 | 62.00M | -19.58% |
| Dec 31, 2014 | 77.10M | 1.72% |
| Nov 11, 2014 | 75.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Humacyte | 206.50M |
| Atrium Therapeutics | 205.26M |
| Canton Strategic Holdings | 205.10M |
| Milestone Pharmaceuticals | 204.76M |
| Fate Therapeutics | 204.56M |
| Context Therapeutics | 198.46M |
| Elicio Therapeutics | 195.55M |
| Nkarta | 188.88M |